- Home
- DINO vs ELAN Comparison
DINO vs ELAN Comparison
Compare DINO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DINO | ELAN |
|---|---|---|
| Founded | 1947 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 10.3B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | DINO | ELAN |
|---|---|---|
| Price | $50.06 | $24.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $59.40 | $24.44 |
| AVG Volume (30 Days) | 2.3M | ★ 4.7M |
| Earning Date | 02-18-2026 | 02-24-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | ★ 21.43 | N/A |
| EPS | ★ 2.07 | 0.07 |
| Revenue | ★ $26,905,000,000.00 | $4,591,000,000.00 |
| Revenue This Year | N/A | $7.25 |
| Revenue Next Year | $1.92 | $5.69 |
| P/E Ratio | ★ $23.97 | $351.79 |
| Revenue Growth | N/A | ★ 3.08 |
| 52 Week Low | $24.66 | $8.02 |
| 52 Week High | $56.58 | $25.29 |
Technical Indicators
Market Signals| Indicator | DINO | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 54.18 | 62.54 |
| Support Level | $47.80 | $23.67 |
| Resistance Level | $51.21 | $25.29 |
| Average True Range (ATR) | 1.67 | 0.77 |
| MACD | 0.25 | 0.08 |
| Stochastic Oscillator | 66.58 | 76.69 |
Price Performance
Historical ComparisonAbout DINO HF Sinclair Corporation
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.